{"transactions":[{"id":3590779,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":159029,"kind":"person","name":"Sarlis Nicholas J.","position":1,"cik":"0001724151","reported_name":"Sarlis Nicholas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-18T19:03:32.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the option shares will vest and become exercisable upon the closing of a Change of Control transaction (as defined in Mr. Sarlis' stock option grant notice), provided that the Reporting Person remains in continuous service with the Issuer on the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":1.38,"expiration_date":"2019-12-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-008204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724151/000089924319008204/doc4.xml","form_type":"4"}},{"id":3994773,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":159029,"kind":"person","name":"Sarlis Nicholas J.","position":1,"cik":"0001724151","reported_name":"Sarlis Nicholas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-15T19:57:36.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 13, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":70000,"derivative":{"exercise_price":5.24,"expiration_date":"2028-03-12","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-18-020014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724151/000120919118020014/doc4.xml","form_type":"4"}}]}